Ashley Mackey
About Ashley Mackey
Ashley Mackey, age 39, was designated Sanara MedTech’s Principal Accounting Officer on August 29, 2025, after serving as Controller since July 2023; she is a CPA in Texas with a BBA, MPA, and MBA from UT Austin’s McCombs School and prior experience at BNSF Railway (2012–2021, most recently Senior Manager) and Deloitte (started in external audit in 2009) . During her finance tenure, SMTI delivered 2024 net revenue of $86.7M (+33% YoY), and consolidated Adjusted EBITDA of $2.69M vs $0.13M in 2023, while the company’s “Pay vs. Performance” TSR metric indicates a $100 initial investment grew to $112.35 in 2024 (from $82.36 in 2023 and $91.18 in 2022) . SMTI’s insider trading policy prohibits hedging, short sales, and pledging without CEO/CFO pre-approval, supporting alignment with long-term shareholder value .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Sanara MedTech Inc. | Principal Accounting Officer (designated) | 2025–present | Not disclosed |
| Sanara MedTech Inc. | Controller | 2023–2025 | Not disclosed |
| BNSF Railway Company | Various roles; most recently Senior Manager | 2012–2021 | Not disclosed |
| Deloitte | External Audit | 2009–not disclosed | Not disclosed |
External Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| — | None disclosed | — | — |
Fixed Compensation
| Component | 2025 Terms | Notes |
|---|---|---|
| Base salary | Not disclosed | Company stated no changes to compensation arrangements upon designation as principal accounting officer |
| Target bonus % | Not disclosed | Not disclosed in filings reviewed |
| Cash bonus | Not disclosed | Not disclosed in filings reviewed |
| Equity (RSUs/PSUs) | Not disclosed | No new grant terms disclosed with designation |
| Employment agreement | None | Company explicitly stated no employment agreement executed in connection with designation |
Performance Compensation
| Metric | Weighting | Target | Actual | Payout | Vesting |
|---|---|---|---|---|---|
| Not disclosed | — | — | — | — | — |
Equity Ownership & Alignment
- Beneficial ownership (shares, % outstanding): Not disclosed for Ashley Mackey in 2025 proxy; named executive officer and director tables do not include her .
- Options/RSUs breakdown: Not disclosed .
- Pledging/hedging: Company policy prohibits hedging, short sales, options trading, holding in margin accounts, or pledging company securities without CEO/CFO pre-approval .
- Ownership guidelines: Not disclosed for executives (director grant details and insider policy disclosed) .
- Related-party transactions: None requiring Item 404(a) disclosure for Mackey; company states no such transactions .
Employment Terms
| Term | Detail |
|---|---|
| Appointment | Designated Principal Accounting Officer effective August 29, 2025 |
| Employment agreement | None executed in connection with designation |
| Compensation changes at designation | None; “no changes were made to Ms. Mackey’s current compensation arrangements” |
| Severance | Not disclosed for Mackey |
| Change-of-control | Not disclosed for Mackey |
| Non-compete / Non-solicit / Garden leave | Not disclosed for Mackey |
| Family relationships | None with any director or executive officer |
| Related-party transactions | None requiring Item 404(a) disclosure |
Performance & Track Record
Company-level metrics during her finance tenure:
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| TSR – Value of Initial Fixed $100 Investment | $91.18 | $82.36 | $112.35 |
| Metric | 2023 | 2024 |
|---|---|---|
| Net Revenue ($) | $64,989,842 | $86,672,425 |
| Adjusted EBITDA ($) | $127,247 | $2,691,307 |
Context:
- 2024 net revenue +33% YoY; adjusted EBITDA improved materially vs 2023 .
- Segment highlights: Sanara Surgical segment produced 2024 Segment Adjusted EBITDA of $9.15M; THP Segment Adjusted EBITDA was $(6.46)M as the company invested to build the platform .
Compensation Structure Analysis
- Guaranteed vs at-risk pay: Not disclosed for Mackey; no employment agreement and no compensation changes at designation .
- Shift in equity forms (options→RSUs), repricing, discretionary bonuses, metric target changes: Not disclosed for Mackey .
- Clawbacks/tax gross-ups: Not disclosed specific to Mackey; insider trading policy and governance practices described in proxy .
Risk Indicators & Red Flags
- Hedging/pledging: Restricted by policy without CEO/CFO approval (reduces misalignment risk) .
- Related-party transactions: None for Mackey .
- Legal/SEC proceedings: None disclosed for Mackey .
- Sudden departures: Not applicable; her appointment followed finance leadership changes disclosed earlier in 2025 .
- Say-on-pay outcomes: Company-level disclosure present; not specific to Mackey .
Equity Ownership & Alignment (Detail Table)
| Item | Status |
|---|---|
| Shares owned (direct/indirect) | Not disclosed for Mackey |
| Ownership % of outstanding | Not disclosed for Mackey |
| Vested vs unvested | Not disclosed for Mackey |
| Options – exercisable/unexercisable | Not disclosed for Mackey |
| Shares pledged as collateral | Prohibited without CEO/CFO pre-approval per policy |
| Stock ownership guidelines (executives) | Not disclosed for Mackey |
| Compliance with guidelines | Not disclosed for Mackey |
Investment Implications
- Alignment: Absence of an employment agreement and no disclosed compensation changes at designation suggest limited guaranteed protections; insider policy restrictions on hedging/pledging reduce misalignment risk .
- Retention: No severance/change-of-control economics disclosed for Mackey; near-term retention risk appears low given recent promotion, but lack of disclosed long-term incentives could limit retention signal until future grants are observed .
- Trading signals: Without Form 3/4 disclosures or award vesting details, insider selling pressure cannot be assessed; monitor future proxies and 8-Ks for equity grants to the principal accounting officer .
- Execution: Company-level performance (2024 revenue growth +33% YoY; Adjusted EBITDA improvement) and finance leadership transitions in 2025 frame a strengthened finance function; Mackey’s CPA and audit/industry background underpin reporting quality and control oversight .